Zurich-based ZuriMED closed a CHF 14.5 million Series A financing led by Chindex Medical, part of Fosun MedTech. Yellowstone Holding and private investors, including orthopaedic surgeons from Switzerland, Germany, France and the United States, also participated. The capital would support development and regulatory registration of a first product for repairing shoulder rotator cuffs.
ZuriMED's Surgical-Fiberlock platform was being developed for minimally invasive soft-tissue repair. The company, an ETH Zurich biomechanics spin-off, planned to introduce products in the United States and Europe. Separately from the equity round, it announced CHF 2.4 million of non-dilutive support through the Innosuisse Swiss Accelerator programme for development and registration of a second device addressing herniated lumbar discs.
